Brief: Synthaverse Signs Deal With Blau Farmaceutica For BCG 10 Vaccine
29/09/2025 07:40
Sept 29 (Reuters) - Synthaverse SA SVEP.WA: SIGNS AGREEMENT WITH BLAU FARMACEUTICA FOR BCG 10 VACCINE MINIMUM TOTAL ORDER VALUE SET AT 76.3 MILLION ZLOTYS DEAL FOR SALE AND DISTRIBUTION OF BCG 10 VACCINE Source text: ID:nEM2n8X7Ta Further company coverage: SVEP.WA (Reporting by Gdańsk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Synthaverse SA
See all newsBrief: Synthaverse EGM To Vote On Share Capital Increase Via Series X Share Issue
Brief: Synthaverse Gets 45 Mln Zloty Loan From Polish Agency For Enterprise Development For Debt Refinancing
Brief: Synthaverse Receives Registration Certificate For Onko BCG Product In Paraguay Under Partnership With Blau
Brief: Synthaverse H1 Net Loss At 6.4 Mln Zlotys
Brief: Synthaverse Gets Poland's GIF Decision Extending Manufacturing For New Immunological Products Facility